2.9(top 20%)
impact factor
788(top 20%)
papers
16.3K(top 10%)
citations
53(top 10%)
h-index
3.2(top 20%)
impact factor
935
all documents
17.0K
doc citations
78(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Emerging PEGylated drugsExpert Opinion on Emerging Drugs2009226
2What is the future of PEGylated therapies?Expert Opinion on Emerging Drugs2015193
3Emerging treatments for traumatic brain injuryExpert Opinion on Emerging Drugs2009180
4Transgenic plants in the biopharmaceutical marketExpert Opinion on Emerging Drugs2005172
5Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesityExpert Opinion on Emerging Drugs2008165
6Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosisExpert Opinion on Emerging Drugs2009161
7Emerging treatments for noise-induced hearing lossExpert Opinion on Emerging Drugs2011148
8Emerging anti-HIV drugsExpert Opinion on Emerging Drugs2005137
9Liposomal amphotericin B as a treatment for human leishmaniasisExpert Opinion on Emerging Drugs2012130
10Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics – an updateExpert Opinion on Emerging Drugs2005127
11Disease-modifying drugs in osteoarthritis: current understanding and future therapeuticsExpert Opinion on Emerging Drugs2018119
12Adenosine receptor agonists: from basic medicinal chemistry to clinical developmentExpert Opinion on Emerging Drugs2003117
13Current and emerging pharmacotherapies for treating tobacco dependenceExpert Opinion on Emerging Drugs2006110
14Emerging pharmacotherapy of tinnitusExpert Opinion on Emerging Drugs2009104
15Emerging drugs for the treatment of anxietyExpert Opinion on Emerging Drugs2015102
16Emerging adenosine receptor agonistsExpert Opinion on Emerging Drugs2007100
17Emerging drugs to treat squamous cell carcinomas of the head and neckExpert Opinion on Emerging Drugs201096
18Emerging drugs for high-grade osteosarcomaExpert Opinion on Emerging Drugs201092
19Emerging Bcl-2 inhibitors for the treatment of cancerExpert Opinion on Emerging Drugs201192
20Emerging pharmacological strategies in the fight against cocaine addictionExpert Opinion on Emerging Drugs200691
21Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of Type 2 diabetes and atherosclerosisExpert Opinion on Emerging Drugs200691
22Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agentsExpert Opinion on Emerging Drugs200288
23Emerging drugs for Duchenne muscular dystrophyExpert Opinion on Emerging Drugs201287
24Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetesExpert Opinion on Emerging Drugs200884
25Emerging drugs for uveitisExpert Opinion on Emerging Drugs201183
26Advances in pharmacotherapy for tobacco dependenceExpert Opinion on Emerging Drugs200482
27Advances in ischemic stroke treatment: neuroprotective and combination therapiesExpert Opinion on Emerging Drugs200782
28Emerging drugs for osteoarthritisExpert Opinion on Emerging Drugs201182
29Emerging medication for the treatment of male hypogonadismExpert Opinion on Emerging Drugs201282
30Advances in emerging drugs for osteosarcomaExpert Opinion on Emerging Drugs201582
31Developments in the treatment of visceral leishmaniasisExpert Opinion on Emerging Drugs200979
32Treatment of Type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitorsExpert Opinion on Emerging Drugs200478
33Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesityExpert Opinion on Emerging Drugs201275
34The future is today: emerging drugs for the treatment of erectile dysfunctionExpert Opinion on Emerging Drugs201074
35Emerging drugs for major depressive disorderExpert Opinion on Emerging Drugs201274
36Histone modification enzymes: novel targets for cancer drugsExpert Opinion on Emerging Drugs200470
37Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degenerationExpert Opinion on Emerging Drugs201770
38Therapeutic options to target angiogenesis in human malignanciesExpert Opinion on Emerging Drugs200668
39Drugs in the medical treatment of Cushing's syndromeExpert Opinion on Emerging Drugs200968
40“Is there an emerging need for new antifungals?”Expert Opinion on Emerging Drugs201668
41Emerging drugs in neuropathic painExpert Opinion on Emerging Drugs200765
42Cancer vaccines: on the threshold of successExpert Opinion on Emerging Drugs200863
43Emerging treatment for chronic migraine and refractory chronic migraineExpert Opinion on Emerging Drugs201263
44Emerging human papillomavirus vaccinesExpert Opinion on Emerging Drugs201262
45Emerging drugs for neuropathic painExpert Opinion on Emerging Drugs201462
46Immunosuppressants in advanced clinical development for organ transplantation and selected autoimmune diseasesExpert Opinion on Emerging Drugs200359
47Emerging potential of exosomes and noncoding microRNAs for the treatment of neurological injury/diseasesExpert Opinion on Emerging Drugs201559
48Potential therapeutic targets for neurokinin-1 receptor antagonistsExpert Opinion on Emerging Drugs200458
49Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugsExpert Opinion on Emerging Drugs202057
50Emerging drug therapies for benign prostatic hyperplasiaExpert Opinion on Emerging Drugs200656